🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
To assess the efficacy and safety of adebrelimab in combination with apatin...
Status
Unknown
Location
The First Affiliated Hospital of Henan University of Science and Technology
Start Date
2024-07-15
Trial ID
NCT06464614
Treatments Being Tested
To observe and evaluate the efficacy and safety of neoadjuvant long-course ...
Status
Active Not Recruiting
Location
No. 150, Haping Road, Nangang District, Harbin, Heilongjiang Province, China
Start Date
2026-05-29
Trial ID
NCT07687433
Treatments Being Tested
In patients with locally advanced oral squamous cell carcinoma (OSCC), due ...
Status
Completed
Location
Shanghai Ninth People's Hospital
Start Date
2020-04-23
Trial ID
NCT04393506
Treatments Being Tested
The purpose of this study is to confirm the safety and efficacy of Apatinib...
Status
Unknown
Location
Henan Cancer Hospital
Start Date
2017-07-05
Trial ID
NCT03424291
Treatments Being Tested
The study includes the screening period (from the time the subject signs th...
Status
Enrolling By Invitation
Location
The Second Affiliated Hospital of Nanchang University
Start Date
2024-11-01
Trial ID
NCT06773156
Treatments Being Tested
This study plans to enroll limited-stage small cell lung cancer (LS-SCLC) p...
Status
Not Yet Recruiting
Location
Peking University Cancer Hospital & Institute
Start Date
2026-01-31
Trial ID
NCT07357532
Treatments Being Tested
Glioma is the most common primary malignant Brain Tumor. Although the tradi...
Status
Unknown
Location
the Second Hospital of Hebei Medical University
Start Date
2019-05-06
Trial ID
NCT03741244
Treatments Being Tested
SHR-1210 is a humanized anti-PD1 IgG4 monoclonal antibody. This is an openl...
Status
Unknown
Location
Department of Radiation Oncology, Tianjin Medical University Cancer Hospital
Start Date
2018-09-17
Trial ID
NCT03671265
Treatments Being Tested
The purpose of this study is to assess the efficacy and safety of patients ...
Status
Unknown
Location
The Fourth Hospital of Hebei Medical University
Start Date
2017-11-30
Trial ID
NCT03349866
Treatments Being Tested
A prospective, single-center, phase II clinical study of adebrelimab combin...
Status
Active Not Recruiting
Location
Chongqing University Cancer Hospital
Start Date
2024-08-13
Trial ID
NCT06700421
Treatments Being Tested